A detailed history of Rise Advisors, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Rise Advisors, LLC holds 47 shares of FLGT stock, worth $869. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47
Previous 159 70.44%
Holding current value
$869
Previous $3,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$19.6 - $25.06 $2,195 - $2,806
-112 Reduced 70.44%
47 $1,000
Q2 2024

Jul 09, 2024

SELL
$19.09 - $22.57 $515 - $609
-27 Reduced 14.52%
159 $3,000
Q4 2023

Jan 10, 2024

SELL
$23.64 - $30.27 $4,066 - $5,206
-172 Reduced 48.04%
186 $5,000
Q3 2023

Oct 10, 2023

SELL
$26.74 - $40.81 $1,203 - $1,836
-45 Reduced 11.17%
358 $9,000
Q3 2022

Oct 11, 2022

SELL
$37.92 - $63.74 $1,971 - $3,314
-52 Reduced 11.43%
403 $15,000
Q4 2021

Feb 24, 2022

BUY
$77.3 - $105.0 $35,171 - $47,775
455 New
455 $45.8 Million

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $560M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Rise Advisors, LLC Portfolio

Follow Rise Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rise Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rise Advisors, LLC with notifications on news.